Skip to main content
Log in

Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutations

  • REVIEW
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Mutations in the parkin gene (PARK2) are the most frequent cause of autosomal recessive early–onset Parkinson disease. We performed a transcranial magnetic stimulation study in four patients with parkin mutations. Two patients had a prolonged central motor conduction time at both upper and lower limb, one only at the arm and one only at the leg. The MEP threshold was increased in one patient for the arm and in two for the leg. The MEP amplitude was reduced in one and central silent period shortened in two. The findings demonstrate corticospinal dysfunction in these patients and suggest that the extent of central nervous system involvement in parkin disease may be wider that hitherto supposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits. Neural substrates of parallel processing. Trends Neurosci 13:266–271

    Article  CAS  PubMed  Google Scholar 

  2. Berardelli A, Rona S, Inghilleri M, et al. (1996) Cortical inhibition in Parkinson’s disease. A study with paired magnetic stimulation. Brain 119:71–77

    PubMed  Google Scholar 

  3. Cantello R, Gianelli M, Bettucci D, et al. (1991) Parkinson’s disease rigidity: Magnetic motor evoked potentials in a small hand muscle. Neurology 41:1449–1456

    CAS  PubMed  Google Scholar 

  4. Davey NJ, Dick JPR, Ellaway PH, et al. (1991) Raised motor cortical threshold associated with bradykinesia as revealed by transcranial magnetic stimulation in normal man and Parkinson’s disease. J Physiol 438:35P

    Google Scholar 

  5. Eisen A, Siejka S, Schulzer M, et al. (1991) Age–dependent decline in motor evoked potential (MEP) amplitude: with a comment on changes in Parkinson’s disease. Electroenceph Clin Neurophysiol 81:209–215

    CAS  PubMed  Google Scholar 

  6. Fahn S, Elton RI, and members of the UPDRS Development Committee (1987) Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent Developments in Parkinson’s disease, vol 2. Florham Park, NJ:MacMillian Health Care Information, pp 153–163

  7. Farrer M, Chan P, Chen R, et al. (2001) Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 50:293–300

    Article  CAS  PubMed  Google Scholar 

  8. Fuhr P, Agostino R, Hallett M (1991) Spinal motor neuron excitability during the silent period after cortical stimulation. Electroenceph Clin Neurophysiol 81:257–262

    CAS  PubMed  Google Scholar 

  9. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442

    CAS  PubMed  Google Scholar 

  10. Itier JM, Ibanez P, Mena MA, et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12:2277–2291

    Article  CAS  PubMed  Google Scholar 

  11. Lohmann E, Periquet M, Bonifati V, et al. (2003) How much phenotypic variation can be attributed to parkin genotype? Ann Neurol Aug 54:176–185

    CAS  Google Scholar 

  12. Lücking CB, Dürr A, Bonifati V, et al. (2000) Association between early–onset Parkinson’s disease and mutations in the parkin gene. N Engl J Med 342:1560–1567

    PubMed  Google Scholar 

  13. Mata IF, Lockhart PJ, Farrer MJ (2004) Parkin genetics: one model for Parkinson’s disease. Hum Mol Genet Apr 1; 13 Spec No 1:R127–33. Epub 2004 Feb 19

    Article  CAS  PubMed  Google Scholar 

  14. Mori H, Kondo T, Yokochi M, et al. (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 51:890–892

    CAS  PubMed  Google Scholar 

  15. Periquet M, Latouche M, Lohmann E, et al. (2003) Parkin mutations are frequent in patients with isolated early–onset parkinsonism. Brain 126:1271–1278

    Article  PubMed  Google Scholar 

  16. Priori A, Berardelli A, Inghilleri M, et al. (1994) Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson’s disease and drug–induced parkinsonism. Brain 117:317–323

    PubMed  Google Scholar 

  17. Ridding MC, Inzelberg R, Rothwell JC (1995) Changes in excitability of motor cortical circuitry in patients with Parkinson’s disease. Ann Neurol 37:181–188

    Article  CAS  PubMed  Google Scholar 

  18. Rossini, P, Barker AT, Berardelli A, et al. (1994) Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroenceph Clin Neurophysiol 91:79–92

    CAS  PubMed  Google Scholar 

  19. Rossini P, Berardelli A, Deuschl G, et al. (1999) Application of magnetic cortical stimulation. “Recommendations for the practice of clinical neurophysiology: guidelines of the international federation of clinical neurophysiology”. chapter 3. 5. Editors Gunther Deuschl and Andrew Eisen, Electroenceph Clin Neurophysiol supplement 52

  20. Valls–Solè J, Pascual–Leone A, Brasil– Neto JP, et al. (1994) Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson’s disease. Neurology 44:735–741

    PubMed  Google Scholar 

  21. van de Warrenburg BPC, Lammens M, Lücking CB, et al. (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 56:555

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. De Michele MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Rosa, A., Volpe, G., Marcantonio, L. et al. Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutations. J Neurol 253, 275–279 (2006). https://doi.org/10.1007/s00415-006-0096-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0096-0

Key words

Navigation